Search results
Wall Street plunges after US inflation shock
The Telegraph via Yahoo Finance· 1 day agoUS stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two years just as inflation jumped.
GlaxoSmithKline Sues Pfizer and BioNTech Over Covid-19 Vaccine Technology
US News & World Report· 1 day agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
James Whittle, PhD
The National Law Review· 5 days agoJames is an experienced patent attorney and accomplished research scientist who advises life sciences companies on patent prosecution matters. James works ...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 2 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
CureVac to cut costs in restructuring
BioPharma Dive via Yahoo Finance· 3 days agoThe mRNA vaccine maker, which has lost most of its value since early 2021, is undergoing an “organizational redesign” that will eliminate 150 positions.
The path to a better tuberculosis vaccine runs through Montana
KPAX Missoula· 6 days agoA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people ...
Merck's first-quarter results beat expectations amid healthy vaccine-sales growth
Morningstar· 2 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts' expectations amid strong sales of vaccines and cancer drug Keytruda. First-quarter adjusted ...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 1 day agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Another view: New NIST framework threatens Texas' innovation excellence
Amarillo Globe-News via Yahoo News· 6 days agoSince then, Bayh-Dole has propelled scientific innovation. The...Dole has enabled close to $2 trillion in gross industrial output, supported 6.5 million jobs, and resulted in the development ...
Moderna Investors Should Beware Patent-Dispute Fallout (NASDAQ:ABUS)
Seeking Alpha· 3 days agoModerna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.